Drug Shortage Report for PMS-TENOFOVIR
| Report ID | 227785 |
| Drug Identification Number | 02453940 |
| Brand name | PMS-TENOFOVIR |
| Common or Proper name | TENOFOVIR |
| Company Name | PHARMASCIENCE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TENOFOVIR DISOPROXIL FUMARATE |
| Strength(s) | 300MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 30 |
| ATC code | J05AF |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-05-09 |
| Estimated end date | 2024-09-06 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-05-10 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-05-10 | French | Compare |
| v1 | 2024-05-10 | English | Compare |
Showing 1 to 2 of 2